American Journal of Clinical Medicine Research
ISSN (Print): 2328-4005 ISSN (Online): 2328-403X Website: Editor-in-chief: Dario Galante
Open Access
Journal Browser
American Journal of Clinical Medicine Research. 2019, 7(1), 9-13
DOI: 10.12691/ajcmr-7-1-2
Open AccessArticle

Tubular Injury in Children with Steroid-resistant Nephrotic Syndrome

Selli Muljanto1, , Sudung O. Pardede2 and Partini P. Trihono2

1Child Health Department, Faculty of Medicine, Universitas Lambung Mangkurat, Banjarmasin, Indonesia

2Child Health Department, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia

Pub. Date: January 14, 2019

Cite this paper:
Selli Muljanto, Sudung O. Pardede and Partini P. Trihono. Tubular Injury in Children with Steroid-resistant Nephrotic Syndrome. American Journal of Clinical Medicine Research. 2019; 7(1):9-13. doi: 10.12691/ajcmr-7-1-2


Tubular lesion is frequently found in steroid-resistant nephrotic syndrome (SRNS) with massive proteinuria, which produces proximal tubular dysfunction. The presence of tubulointerstitial injury will assist the selection of therapy in nephrotic syndrome (NS) patients. Tubular injury can be diagnosed using tubular function test such as fractional excretion of magnesium (FE Mg) and urinary β2-microglobulin (β2M) in addition to kidney biopsy. The aim of this study was to compare the FE Mg and urinary β2M in children with SRNS and steroid-sensitive nephrotic syndrome (SSNS) in order to be able to detect the presence of tubular injury on SRNS. A cross-sectional study was conducted on children aged 2-15 years with SRNS and SSNS in remission. The urinary β2M and FE Mg were examined on 31 subjects of SRNS and SSNS in remission respectively. The urinary β2M was measured using competitive binding enzyme immunoassay. Serum and urinary magnesium and creatinine were measured using colorimetric and enzymatic colorimetry method respectively, afterwards FE Mg calculated with the formula: . The mean of FE Mg in SRNS (2.34 (SD 1.37) %) was significantly higher than the SSNS in remission (1.59 (SD 0.85) %; p = 0.0065), as well the median of urinary β2M level in SRNS (0.50 (0.30-11.80) µg/mL) was higher than the SSNS in remission (0.40 (0.30-0.50) µg/mL; p <0.001). The urinary β2M was increased significantly in SRNS compared to SSNS (26/31 subjects vs 16/31 subjects, respectively; p = 0.007). The increase of FE Mg in SRNS is significantly higher than in SSNS in remission with a cut off point of 1.64% (21/31 subjects vs 11/31 subjects, respectively; p = 0.022). The FE Mg and urinary β2M level are higher in SRNS than SSNS in remission that indicate tubular injury in SRNS.

fractional excretion of magnesium steroid-resistant nephrotic syndrome tubular injury urinary β2-microglobulin

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Mekahli D, Liutkus A, Ranchin B, et al. “Longterm outcome of idiopathic steroid‐resistant nephrotic syndrome: a multicenter study”. Pediatr Nephrol. 2009;24(8):1525‐32. Aug 2009.
[2]  Hoyer PF, Vester U, Becker U. Steroid resistant nephrotic syndrome. In: Geary DF, Schaefer F, editors. Comprehensive Pediatric Nephrology. 1st ed. Mosby, Elsevier, Philadelphia, 2008. 257-67.
[3]  Seif EI, Ibrahim EAS, Elhefnawy NG, Salman MI. “Histological patterns of idiopathic steroid resistant nephrotic syndrome in Egyptian children: a single centre study”. J Nephropathol. 2013;2(1):53-60. Jan 2013.
[4]  Bagga A, Srivastava RN. “Nephotic syndrome”. In: Srivasta RN, Bagga A, editors. Pediatric nephrology. 5th ed. Jaypee Brothers Medical Publishers, New Delhi, 2011. 219-24.
[5]  Tsampalieros A, Gupta P, Denburg MR, et al. “Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome”. J Bone Miner Res. 2013; 28(3): 480-8. Mar 2013.
[6]  Ghobrial EE, Fahmey SS, Ahmed ME, Botros OE. “Behavioral changes in Egyptian children with nephrotic syndrome”. Iranian J Kid Dis. 2013; 7(2): 108-16. Mar 2013.
[7]  Chavan S, Hase N, Chavan P. “Urinary β2 microglobulin and lysozyme in nephrotic syndrome”. Indian J Nephrol. 2005; 15: 84-90. Jul-Sept 2005.
[8]  Caliskan S, Hacibekiroglu M, Sever L, Osbay G, Arisoy N. “Urinary N-acetyl-β-D-glucosaminidase and β2-microglobulin excretion in primary nephrotic children”. Nephron. 1996; 74(2): 401-4. Feb 1996.
[9]  Vallés P, Peralta M, Carriz L, et al. “Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria”. Pediatr Nephrol. 2000; 15(3-4): 252-8. Dec 2000.
[10]  Eddy AA. “Proteinuria and interstitial injury”. Nephrol Dial Transplant. 2004; 19(2): 277-81. Feb 2004.
[11]  Nangaku M. “Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure”. Intern Med. 2004; 43(1):9-17. Jan 2004.
[12]  Narchi H. “Assessment and management of non-nephrotic range proteinuria in children”. Sri Lanka J Child Health. 2008; 37: 85-92. Sep 2008.
[13]  Gulati S, Sengupta D, Sharma RK, et al. “Steroid resistant nephrotic syndrome: Role of histopathology”. Indian Pediatrics. 2006; 43(1): 55‐60. Jan 2006.
[14]  Ichikawa I, Fogo A. “Focal segmental glomerulosclerosis”. Pediatr Nephrol. 1996; 10: 374-91. Jan 1996.
[15]  Rumana J, Hanif M, Muinuddin G, Maruf-ul-Quader M. “Correlation of fractional excretion of magnesium with steroid responsiveness in children with nephrotic syndrome”. Saudi J Kidney Dis Transpl. 2014; 25(4):830-6. Jul 2014.
[16]  Deekajorndech T. “A biomarker for detecting early tubulointerstitial disease and ischemia in glomerulonephropathy”. Ren Fail. 2007; 29(8): 1013-7. Jul 2009.
[17]  Futrakul P, Yenrudi S, Futrakul N, et al. “Tubular function and tubulointerstitial disease”. Am J Kidney Dis. 1999; 33(5): 886-91. May 1999.
[18]  Portman RJ, Kissane JM, Robson AM. “Use of beta 2-microglobulin to diagnose tubulo-interstitial renal lesions in children”. Kidney Int. 1986; 30: 91-8. Jul 1986.
[19]  Zeng X, Hossain D, Bostwick DG, Herrera GA, Ballester B, Zhang PL. “Urinary β2-microglobulin is a sensitive indicator for renal tubular injury”. SAJ Case Rep. 2014; 1(1): 103-8. Aug 2014.
[20]  Friedman A. Laboratory assessment and investigation of renal function. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, editors. Pediatric Nephrology. 6th ed. Springer-Verlag, Berlin Heidelberg. 2009. 491-504.
[21]  Deekajorndech T. “Fractional excretion of magnesium in systemic lupus erythematosus”. J Med Assoc Thai. 2005; 88(6): 743-5. Jun 2005.
[22]  Olowu WA, Adelusola KA, Adefehinti O. “Childhood idiopathic steroid resistant nephrotic syndrome in Southwestern Nigeria”. Saudi J Kidney Dis Transpl. 2010; 21(5): 979-90. Sept 2010.
[23]  Madani A, Fahimi D, Taghaodi R, Mahjoob F, Hajizadeh N, Navabi B. “An estimation of steroid responsiveness of idiopathic nephrotic syndrome in Iranian children”. Iran J Pediatr. 2010; 20(2): 199-205. Jun 2010.
[24]  Futrakul N, Yenrudi S, Futrakul P, et al. “Peritubular capillary flow and tubular function in idiopathic nephrotic syndrome”. Nephron. 2000; 85: 181-2. Jun 2000.
[25]  Niaudet P, Boyer O. Idiopathic nephrotic syndrome in children: Clinical aspects. In: Avner ED, Harmon WE, Niaudet P, Yashikawa N, editors. Pediatric nephrology. 6th ed. Springer-Verlag, Berlin Heidelberg, 2009. 667-702.
[26]  Mubarak M, Lanewala A, Kazi JI, et al. “Histopathological spectrum of childhood nephrotic syndrome in Pakistan”. Clin Exp Nephrol. 2009; 13: 589‐93. Jul 2009.
[27]  Singh K, Ray R, Sharma A, Gupta R, Bagga A, Dinda AK. “Peritubular capillaries and renal function in pediatric idiopathic nephrotic syndrome”. Saudi J Kidney Dis Transpl. 2013; 24(5): 942-9. Sept 2013.
[28]  Bussolati B, Camussi G. New insights into the renal progenitor cells and kidney diseases by studying cd133. In: D. Corbeil, editor. Prominin-1 (CD133): New Insights on Stem & Cancer Stem Cell Biology, Advances in Experimental Medicine and Biology. Springer Science+Business Media, New York, 2013. 113-23.
[29]  Bianchetti MG, Bettinelli A. Differential diagnosis and management of fluid, electrolyte, and acid-base disorders. In: Geary DF, Schaefer F, editors. Comprehensive Pediatric Nephrology.1st ed. Mosby Elsevier, Philadelphia, 2008. 395-401.
[30]  Bianchi C, Donadio C, Tramonti G, Consani C, Lorusso P, Rossi G. “Reappraisal of serum beta2-microglobulin as marker of GFR”. Ren Fail. 2001; 23(3&4): 419-29. Jul 2009.
[31]  Trof RJ, Di Maggio F, Leemreis J, Groeneveld AB. “Biomarkers of acute renal injury and renal failure”. Shock. 2006; 26(3): 245-53. Mar 2006.